The results by other authors have suggested that serum L-Selectin could be of prognostic value in ovarian cancer [42] and liver cancer [47] while Li et al. [83] suggested that the detection of protein expression of L-Selectin conduces to judging the prognosis of colorectal cancer patients. Here, SELL is linked to ovarian carcinoma.